Evidence map›Paper›PMID 35937420›Full record

ArticleFrontiers in digital health2022

Implementation of Electronic Adherence Monitors and Associated Interventions for Routine HIV Antiretroviral Therapy in Uganda: Promising Findings.

Jessica E Haberer, Robert Baijuka, John Bosco Tumuhairwe, Edna B Tindimwebwa, James Tinkamanyire, Ellyk Tuhanamagyezi, Lawrence Musoke, Lindsey E Garrison, Marisa DelSignore, Nicholas Musinguzi and 1 more

Registry-linked trialOpen access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in digital health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03825952 (Optimizing mHealth for Adherence Monitoring and Intervention), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03825952 nacompletednot on this map

Optimizing mHealth for Adherence Monitoring and Intervention

TypeinterventionalSponsorMassachusetts General HospitalRan2018 to 2022Enrolled174ConditionsHIV/AIDSArmsMERM - medication event reminder monitor
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jessica E HabererCenter for Global Health, Massachusetts General Hospital, Boston, MA, United States.
Robert BaijukaKabwohe Clinical Research Centre, Kabwohe, Uganda.
John Bosco TumuhairweKabwohe Clinical Research Centre, Kabwohe, Uganda.
Edna B TindimwebwaKabwohe Clinical Research Centre, Kabwohe, Uganda.
James TinkamanyireKabwohe Clinical Research Centre, Kabwohe, Uganda.
Ellyk TuhanamagyeziKabwohe Clinical Research Centre, Kabwohe, Uganda.
Lawrence MusokeKabwohe Clinical Research Centre, Kabwohe, Uganda.
Lindsey E GarrisonCenter for Global Health, Massachusetts General Hospital, Boston, MA, United States.
Marisa DelSignoreCenter for Global Health, Massachusetts General Hospital, Boston, MA, United States.
Nicholas MusinguziCenter for Global Health, Massachusetts General Hospital, Boston, MA, United States.
Stephen AsiimweCenter for Global Health, Massachusetts General Hospital, Boston, MA, United States.
Massachusetts General Hospital · USCenter for Global Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: High, sustained adherence is critical for achieving the individual and public health benefits of HIV antiretroviral therapy (ART). Electronic monitors provide detailed adherence information and can enable real-time interventions; however, their use to date has largely been confined to research. This pilot study (NCT03825952) sought to understand feasibility and acceptability a relatively low-cost version of this technology and associated interventions for routine ART delivery in sub-Saharan Africa. Methods: We provided two ART clinics in rural, southwestern Uganda with electronic adherence monitors for data-informed counseling as well as optional SMS messages to clients and/or social supporters (daily or triggered by missed or delayed doses) and/or an alarm. Clinic and ART client experiences were observed for 3 months per client, including time and motion studies. Qualitative interviews among clients, clinicians, and healthcare administrators were informed by the Consolidated Framework for Implementation Research. Results: Fifty-one ART clients were enrolled; 57% were male and the median age was 34 years. Choice of associated intervention varied among participants. The median number of visits during follow-up was two per client. Counselors reviewed the adherence data with 90% of clients at least once; 67% reviewed data at all visits. Average adherence was 94%; four clients had adherence gaps >1 week. Acceptability was high; all but one client found the monitor "very useful" and all found SMS "very useful." Clinic visits among clients with the intervention lasted 4 min longer on average than those in standard care. The monitors and daily SMS generally functioned well, although excess SMS were triggered, primarily due to cellular network delays. Overall, participants felt the technology improved adherence, clinic experiences, and clinician-client relationships. Few worried about stigma and privacy. Cost was a concern for implementation, particularly at scale. Conclusion: We successfully implemented a relatively low-cost electronic ART adherence monitor and associated interventions for routine care in rural Uganda. Feasibility and acceptability were generally high, and individuals were identified who could benefit from adherence support. Future work should involve longitudinal follow-up of diverse populations, clinical outcomes, and detailed cost-effectiveness analysis to help drive policy decisions around the uptake of this technology for routine clinical care. Clinical Trial Registration: identifier: NCT03825952.

Indexed as

Africaelectronic adherence monitoringHIVimplementation scienceSMS intervention

Identifiers

PMID35937420
PMCPMC9354256
OpenAlexW4286717245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.